company background image
APR

ApriaNasdaqGS:APR Stock Report

Last Price

US$37.26

Market Cap

US$1.3b

7D

-0.3%

1Y

n/a

Updated

20 Jan, 2022

Data

Company Financials +
APR fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance3/6
Financial Health3/6
Dividends0/6

APR Stock Overview

Apria, Inc. provides integrated home healthcare equipment and related services in the United States.

Apria Competitors

MEDNAX

NYSE:MD

US$2.1b

Edwards Lifesciences

NYSE:EW

US$72.1b

ResMed

NYSE:RMD

US$34.8b

West Pharmaceutical Services

NYSE:WST

US$27.7b

Price History & Performance

Summary of all time highs, changes and price drops for Apria
Historical stock prices
Current Share PriceUS$37.26
52 Week HighUS$40.00
52 Week LowUS$20.07
Beta0
1 Month Change21.49%
3 Month Change6.15%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO59.50%

Recent News & Updates

Oct 07
Calculating The Fair Value Of Apria, Inc. (NASDAQ:APR)

Calculating The Fair Value Of Apria, Inc. (NASDAQ:APR)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Apria, Inc...

Shareholder Returns

APRUS HealthcareUS Market
7D-0.3%-2.1%-4.0%
1Yn/a12.8%6.6%

Return vs Industry: Insufficient data to determine how APR performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how APR performed against the US Market.

Price Volatility

Is APR's price volatile compared to industry and market?
APR volatility
APR Average Weekly Movement9.2%
Healthcare Industry Average Movement8.0%
Market Average Movement6.6%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.4%

Stable Share Price: APR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: APR's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20186,290Dan Starckhttps://www.apria.com

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients.

Apria Fundamentals Summary

How do Apria's earnings and revenue compare to its market cap?
APR fundamental statistics
Market CapUS$1.32b
Earnings (TTM)US$72.26m
Revenue (TTM)US$1.14b

18.3x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
APR income statement (TTM)
RevenueUS$1.14b
Cost of RevenueUS$236.77m
Gross ProfitUS$905.77m
ExpensesUS$833.51m
EarningsUS$72.26m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)2.03
Gross Margin79.28%
Net Profit Margin6.32%
Debt/Equity Ratio1,653.2%

How did APR perform over the long term?

See historical performance and comparison

Valuation

Is Apria undervalued compared to its fair value and its price relative to the market?

18.32x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: APR ($37.26) is trading above our estimate of fair value ($13.25)

Significantly Below Fair Value: APR is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: APR is good value based on its PE Ratio (18.3x) compared to the US Healthcare industry average (20.5x).

PE vs Market: APR is poor value based on its PE Ratio (18.3x) compared to the US market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: APR is poor value based on its PEG Ratio (3.2x)


Price to Book Ratio

PB vs Industry: APR is overvalued based on its PB Ratio (57.2x) compared to the US Healthcare industry average (2.6x).


Future Growth

How is Apria forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

5.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: APR's forecast earnings growth (5.6% per year) is above the savings rate (2%).

Earnings vs Market: APR's earnings (5.6% per year) are forecast to grow slower than the US market (13.1% per year).

High Growth Earnings: APR's earnings are forecast to grow, but not significantly.

Revenue vs Market: APR's revenue (4.7% per year) is forecast to grow slower than the US market (9.3% per year).

High Growth Revenue: APR's revenue (4.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: APR's Return on Equity is forecast to be very high in 3 years time (58.6%).


Past Performance

How has Apria performed over the past 5 years?

-5.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: APR has a large one-off loss of $30.9M impacting its September 30 2021 financial results.

Growing Profit Margin: APR's current net profit margins (6.3%) are higher than last year (2.4%).


Past Earnings Growth Analysis

Earnings Trend: APR's earnings have declined by 5.2% per year over the past 5 years.

Accelerating Growth: APR's earnings growth over the past year (177.4%) exceeds its 5-year average (-5.2% per year).

Earnings vs Industry: APR earnings growth over the past year (177.4%) exceeded the Healthcare industry 32.5%.


Return on Equity

High ROE: Whilst APR's Return on Equity (319.04%) is outstanding, this metric is skewed due to their high level of debt.


Financial Health

How is Apria's financial position?


Financial Position Analysis

Short Term Liabilities: APR's short term assets ($324.1M) exceed its short term liabilities ($274.3M).

Long Term Liabilities: APR's short term assets ($324.1M) do not cover its long term liabilities ($431.7M).


Debt to Equity History and Analysis

Debt Level: APR's net debt to equity ratio (717.2%) is considered high.

Reducing Debt: Insufficient data to determine if APR's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: APR's debt is well covered by operating cash flow (48.8%).

Interest Coverage: APR's interest payments on its debt are well covered by EBIT (12.9x coverage).


Balance Sheet


Dividend

What is Apria current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate APR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate APR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if APR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if APR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of APR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.8yrs

Average management tenure


CEO

Dan Starck (54 yo)

9.75yrs

Tenure

US$2,199,252

Compensation

Mr. Daniel J. Starck, also known as Dan, has been Chief Executive Officer at Apria, Inc. since February 2015 and has been its Director December 2013. Mr. Starck served as the Chief Executive Officer of Apr...


CEO Compensation Analysis

Compensation vs Market: Dan's total compensation ($USD2.20M) is below average for companies of similar size in the US market ($USD3.72M).

Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: APR's management team is seasoned and experienced (8.8 years average tenure).


Board Members

Experienced Board: APR's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: APR only recently listed within the past 12 months.


Top Shareholders

Company Information

Apria, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Apria, Inc.
  • Ticker: APR
  • Exchange: NasdaqGS
  • Founded: 2018
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$1.324b
  • Shares outstanding: 35.52m
  • Website: https://www.apria.com

Number of Employees


Location

  • Apria, Inc.
  • 7353 Company Drive
  • Indianapolis
  • Indiana
  • 46237
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/20 23:50
End of Day Share Price2022/01/20 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.